Market Access/ News/ News AbbVie won’t enforce patents for COVID-19 drug candidate Kaletra Phil Taylor AbbVie, coronavirus, kaletra, patent 0 Comment AbbVie has said it won’t defend patent rights to its HIV therapy Kaletra in the hope that it Share X AbbVie won’t enforce patents for COVID-19 drug candidate Kaletra https://pharmaphorum.com/news/abbvie-wont-enforce-patents-for-covid-19-drug-candidate-kaletra/
News/ News/ R&D AbbVie’s Kaletra doesn’t work in COVID-19, say Chinese scientists Phil Taylor AbbVie, coronavirus, kaletra 0 Comment A clinical trial of AbbVie’s HIV therapy Kaletra conducted by researchers in China has undermined hopes it could Share X AbbVie’s Kaletra doesn’t work in COVID-19, say Chinese scientists https://pharmaphorum.com/news/abbvies-kaletra-doesnt-work-in-covid-19-say-chinese-scientists/
